Tocilizumab cost effective in reducing COVID-19-related deaths.
PharmacoEcon Outcomes News
; 879(1): 28, 2021.
Article
in English
| MEDLINE | ID: covidwho-1252292
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
Language:
English
Journal:
PharmacoEcon Outcomes News
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS